The Service I received from the Orders and Customer Service Team was very professional. Their responses were very quick and actioned on immediately.

Mr Gueorgui TzvetanovSenior ManagerERGO Austria International AG

The Research and Markets’ customer support team provided me with timely and immediate responses and delivered exactly the information that I was looking for – great job. Thank you very much. I would recommend them to anybody who is looking for market research data.

Great customer service and super responsive. I was having issues with my payment method but Claire in customer service was super responsive to help several times until the issue was entirely resolved. Great job

Mr Detlef RethagePresidentNitto Avecia Inc

The reports ordered are of good quality and are relevant to our business needs.

Mr Etienne AdriansenSenior Director Business EvaluationLEO Pharma

Thank you for all of your help! I think your service is excellent. It is an easy platform to order interesting reports.

Mr Tomi AmberlaConsultantPöyry Management Consulting

The team at Research and Markets are first rate. Their market intelligence is relevant and accurate and the customer service fast, responsive and dependable. I always benefit from knowledge gained from their comprehensive studies and will continue to utilize their services.

Ms Liz DickinsonCEOPhysical Enterprises Inc

I have bought reports from other sources but the report that I bought from Research and Markets was the most detailed of the lot. Their customer service was excellent and I was able to get the report without any fuss.

Mr Naveed KamalAsst Manager: Business DevelopmentRangs Group Ltd

Celebrating 15
years in business
by partnering
with UNICEF for education

FEATURED COMPANIES

Transplantation refers to a surgical procedure involving replacement of a failed or damaged organ, tissue or cell in the human body with a new one. In order to check the donor and recipient compatibility and to monitor the post transplantation rejections the transplantation procedure requires diagnostic tests. It has been one of the most ground breaking and remarkable advancement in the field of diagnostics over the past 60 years improving the long-term survival and quality of life of most patients.

Pre-transplant diagnosis is a procedure performed prior the transplantation of the organ from donor to recipient to check the compatibility of organ by HLA typing and HLA cross matching to avoid graft rejection in the future. Donor is also screened for any infectious diseases to avoid transmission of infection to the recipient. Post-transplantation diagnostic tests are performed to monitor transplant organs from rejection in recipient’s immune system which may result in life threatening conditions.

Blood tests are conducted on regular basis to measure the amount of immunosuppressant medication in patient’s blood where high levels could lead to toxicity and low levels may lead to rejection, hence continuous monitoring of appropriate dosage of drug is required in recipient to monitor rejection. According to our analysis, the transplantation diagnostics global market is expected to grow at a high CAGR to reach $2,059.2 million in 2022. Increased incidence of life style diseases like cancer, diabetes, heart diseases etc., associated with unhealthy habits are likely to damage the organs or tissues, requiring the necessity of transplantation procedures, which is simultaneously expected to propel the growth of transplantation diagnostics market.

Along with these the rising disposable incomes in the developing countries, rapid growth in aging and diseased population provides an opportunity for IVD companies to come up with more number of tests. However some issues like high test cost, limited reimbursement facility, and some ethical issues may hinder the growth of transplantation diagnostics market. If these issues are addressed, there will be a huge growth potential for transplantation diagnostics with added opportunities from new avenues like cell-free DNA which is likely to propel the market with very high growth rate.

The transplantation diagnostics global market is segmented by technology, products, applications, end users, and by geography. The technology market is segmented into two main divisions such as molecular methods and non-molecular methods. Non-Molecular methods market held the largest market revenue and the molecular methods are expected to grow by 2022 growing at a high CAGR from 2015 to 2022, due to the greater sensitivity, accuracy, and resolving power compared to serological typing methods. The transplantation diagnostics market by product type is segmented into three major divisions such as instruments, reagents & consumables and software & services.

Among these, consumables accounts for largest share and is growing strongly at a double digit CAGR due to availability of easy-to-use assay kits for HLA typing based on SSP-PCR, SSOPCR, NGS and serological tests. The transplantation diagnostics market by applications is segmented into two major divisions such as diagnostic and research. Among these, diagnostic accounts for the largest share growing strongly at a double digit CAGR. The transplantation diagnostics market by end-users is segmented into three major divisions such as hospital & transplant centres, diagnostic laboratories and research laboratories, and academic institutions. Among these, hospital and transplant centres accounts for highest share in 2015 are expected to grow by 2022 growing at a high CAGR from 2015 to 2022.This report qualifies for a 'Buy One Get One Free' promotion. Please contact us for more details.

3 Market Analysis3.1 Introduction3.2 Market Segmentation3.3 Factors Influencing Market3.3.1 Drivers And Opportunities3.3.1.1 Increase In The Rate Of Solid Organ, Tissue And Stem Cell Transplantation3.3.1.2 Increase In Geriatric Population Coupled With Chronic Diseases3.3.1.3 Increase In Research Grants And Funding3.3.1.4 Increasing Demand For Early Detection Through Non-Invasive Testing Procedures Using Cell-Free Dna3.3.1.5 Growing Awareness Among People For Organ Donation And Increase In Healthcare Expenditure3.3.1.6 Technological Shift From Serological Assays To Gene-Based Hla Profiling3.3.2 Restraints And Threats3.3.2.1 High Device Cost And Non-Affordability3.3.2.2 Limited Medical Reimbursements For Organ Donation And Transplantation Procedures3.3.2.3 Ethical Issues Related To Transplantation3.3.2.4 Significant Gap Between The Number Of Organs Donated And The Number Of Organs Required Annually Is A Major Challenge Limiting The Growth Of The Global Transplant Diagnostic Market3.4 Regulatory Affairs3.4.1 U.S.3.4.2 Europe3.4.3 India3.4.4 China3.4.5 Japan3.5 Porters Five Force Analysis3.5.1 Threat Of New Entrants3.5.2 Threat Of Substitutes3.5.3 Competitive Rivalry3.5.4 Bargaining Power Of Suppliers3.5.5 Bargaining Power Of Buyers3.6 Market Share Analysis By Major Players3.7 Recent And Upcoming Products